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INTRODUCTION
Intrauterine growth restriction (IUGR) is 
linked to metabolic dysfunction in offspring, 
but the mediating mechanisms are still under in-
vestigation (Barker et al., 1993). IUGR fetuses 
adapt to their poor intrauterine environment by 
repartitioning nutrients to organs critical for 
survival (i.e., brain, heart) at the expense of  tis-
sues such as muscle (Yates et al., 2012c). These 
developmental adaptations help the fetus to 
survive in utero but have lifelong consequences 
in offspring; persistent reduction of  highly 
metabolic muscle mass is detrimental to glucose 
homeostasis (DeFronzo et  al., 1981). Glucose 
metabolism is regulated primarily by insulin, 
and nutrient depravation is associated with 
impaired β-cell mass, insulin secretion, and in-
sulin action in the IUGR fetus (Limesand et al., 
2006). Moreover, inflammation disrupts insulin 
action and aids in the development of  insulin 
resistance (Bach et al., 2013). We recently showed 
that inflammatory cytokines acutely stimu-
late glucose metabolism despite their antagon-
istic effects on insulin signaling (Cadaret et al., 
2017b). However, we hypothesize that chronic 
exposure alters responsiveness to cytokines and 
results in basal cytokine concentrations having 
a greater inhibitory tone. Furthermore, chronic 
maternal inflammation may induce fetal inflam-
matory adaptations that impair muscle growth 
and metabolism. Therefore, our objective was to 
determine the effects of  sustained maternal in-
flammation on fetal growth, islet function, and 
muscle glucose metabolism.
MATERIALS AND METHODS
Animals and Experimental Design
Experiments were approved by the Institutional 
Animal Care and Use Committee at the University 
of Nebraska-Lincoln, which is accredited by 
AAALAC International. Timed-mated Polypay ewes 
were administered saline (control, n = 9) or 0.1 µg/
kg BW (i.v.) of bacterial lipopolysaccharide (LPS; 
n  =  7; E.  coli O55:B5; Sigma-Aldrich) every third 
day from 100 to 115 d of gestation (dGA) to produce 
maternal inflammation-induced IUGR (MI-IUGR) 
fetuses. At 118 ± 2 dGA, indwelling catheters and 
a perivascular flow probe were surgically placed in 
fetal femoral arteries and veins and exteriorized at 
1This project is based on research that was partially sup-
ported by the National Institute of General Medical Sciences 
Grant 1P20GM104320 (J. Zempleni, Director), the Nebraska 
Agricultural Experiment Station with funding from the Hatch 
Act (NEB-26- 224) and Hatch Multistate Research capacity 
funding program (NEB-26- 226, NEB-26- 225) through the 
USDA National Institute of Food and Agriculture.
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the ewe’s flank as previously described (Limesand 
et al., 2007). Maternal and fetal blood samples were 
taken at 123 dGA and complete blood counts (CBC, 
HemaTrue Veterinary Chemistry Analyzer, Heska) 
were performed for total and differential white blood 
cell (WBC) analysis. Glucose-stimulated insulin secre-
tion (GSIS) and hyperinsulinemic-euglycemic clamp 
(HEC) studies were performed at 123 and 124 dGA, 
respectively, and ewes were euthanized at 125  ±  2 
dGA. At necropsy, fetal soleus muscles were isolated 
for ex vivo metabolic studies.
Fetal GSIS Studies
To determine β-cell function, a square-wave 
hyperglycemic clamp was performed at 123 ± 2 dGA 
in control (n = 6) and MI-IUGR fetuses (n = 5) as pre-
viously described (Yates et al., 2012b). Three baseline 
fetal blood samples were collected in 5-min intervals, 
and an intravenous fetal glucose bolus (3,000  mM; 
1 mL/kg fetal BW) was then administered followed 
by continuous variable-rate glucose infusion in order 
to target steady-state glucose concentrations of 
~2.5 mM. After 30 min of steady-state hyperglycemia, 
three fetal blood samples were collected at 5-min 
intervals. Blood collected in EDTA syringes was cen-
trifuged (14,000 × g, 2 min, 4 °C) to isolate plasma to 
determine insulin concentrations via ELISA (Ovine 
Insulin; Alpco). Blood collected in heparin-coated 
syringes underwent blood gas, glucose, and lactate 
analysis using an ABL90 Flex (Radiometer).
Fetal HEC Studies
Hindlimb glucose utilization and oxidation rates 
were evaluated in control (n  =  4) and MI-IUGR 
(n = 4) fetuses at baseline and during HEC at 124 ± 2 
dGA. Fetal lambs were bolused (1  mL, i.v.) with 
U-[14C]-glucose tracer (18.75 µCi/mL; Perkin-Elmer) 
followed by infusion at a constant rate (2 mL/kg/h). 
After 40 min, venous and arterial blood samples were 
collected simultaneously in heparin-coated syringes 
at 5-min intervals (four total draws). Fetuses were 
bolused with glucose (3,000 mM, 2 mL/kg BW) and 
insulin (500 mU/mL; 0.5  mL/kg BW; Humulin-R, 
Eli Lilly) followed by infusion (glucose, variable; in-
sulin, 0.5 mL/kg/h). After HEC was achieved for 2 h, 
venous and arterial blood samples were collected 
simultaneously in 5-min intervals (four total draws) 
as described above. Additional venous and arterial 
blood was collected at each time point to measure 
glucose oxidation. Blood containing glucose tracer 
was added to micro-centrifuge tubes containing 2 M 
HCl suspended inside sealed 20-mL scintillation vial 
with 1 M NaOH at the bottom. HCl releases CO2 
from blood, which is then recaptured by the NaOH 
in the scintillation vial. After 24-h incubation at 
room temperature, the centrifuge tube was removed 
and UltimaGold scintillation fluid (Perkin-Elmer) 
was added to the scintillation vial. Concentrations 
of 14CO2 from each blood sample were quantified 
using a Beckman-Coulter 1900 TA LC counter. 
Hindlimb glucose utilization rate was calculated as 
the difference between arterial and venous samples 
normalized to femoral blood flow rate and hindlimb 
weight. Glucose oxidation rates were determined 
from the difference between venous and arterial 14C 
specific activities normalized to femoral blood flow 
rate and hindlimb weight. Millimoles of glucose oxi-
dized were calculated from blood 14C using the spe-
cific activity of the infused radiolabeled glucose.
Primary Muscle Glucose Metabolism
Skeletal muscle glucose uptake and oxidation 
was determined in control (n = 8) and MI-IUGR 
(n  =  6) fetuses as previously described (Cadaret 
et  al., 2017b). Briefly, fetal soleus muscle was 
dissected longitudinally into ~500-mg strips and 
incubated in Krebs–Henseleit bicarbonate buffer 
(KHB) containing no additive (basal), insulin (5 
mU/mL Humulin-R), or tumor necrosis factor 
alpha (TNFα) (20  ng/mL; Sigma-Aldrich). For 
glucose uptake studies, muscle was incubated in 
treatment-spiked KHB media containing 1  mM 
[3H]2-deoxyglucose for 20  min. For glucose oxi-
dation studies, muscle strips were incubated in 
treatment-spiked KHB media containing [14C-U] 
D-glucose for 2 h, and 14CO2. was captured for 2 h.
Statistical Analysis
All data were analyzed using the Mixed pro-
cedure in SAS (SAS Institute, Cary NC) with 
fetus as the experimental unit. Variables in 
GSIS, HEC, and ex vivo studies were analyzed 
for effects due to treatment, period (or incuba-
tion condition), and interaction, with period/
condition as a repeated variable. For GSIS and 
HEC studies, samples within each period were 
averaged for each fetus. Likewise, three tech-
nical replications/condition were averaged for 
each fetus in ex vivo studies. Fetal weights and 
dGA 123 CBC data were analyzed for effects 
due to treatment. Data are presented as means 
± SEM.
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RESULTS
Fetal Weights and CBC
Fetal weights at necropsy were ~22% less 
(P < 0.05) for MI-IUGR fetuses than for controls. 
At ~123 dGA, circulating WBC, lymphocytes, 
monocytes, and granulocytes were increased 
(P < 0.05) in dams treated with LPS compared 
to those given saline. However, circulating WBC, 
lymphocytes, and monocytes were decreased 
(P  <  0.05) in MI-IUGR fetuses compared to 
controls. Circulating granulocytes were similar in 
all fetuses.
Fetal Insulin Secretion
During square-wave hyperglycemic clamps, glu-
cose was increased (P < 0.05) to similar concentra-
tions in all fetuses by design. At baseline, however, 
Figure  1. Plasma insulin (A) and glucose (B) concentrations at 
basal and hyperglycemic states in control (n = 6) and IUGR (n = 5) 
fetuses during GSIS.
Figure  2. In vivo hindlimb specific glucose uptake (A), glucose 
oxidation (B), and lactate secretion (C) determined under basal and 
hyperinsulinemic clamp conditions in control (n  =  4) and IUGR 
(n = 4) fetuses. a,b,cMeans with differing superscripts differ (P < 0.05).
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plasma glucose concentrations were less (P < 0.05) in 
MI-IUGR fetuses compared to controls (Figure 1). 
In response to hyperglycemia, plasma insulin con-
centrations increased (P < 0.05) from baseline in all 
fetuses, but concentrations at baseline and hypergly-
cemia were substantially less (P < 0.05) in MI-IUGR 
fetuses compared to controls.
Fetal Hindlimb Glucose Utilization
Baseline hindlimb glucose uptake and oxi-
dation rates were similar between MI-IUGR and 
control fetuses (Figure  2). As plasma insulin was 
experimentally increased (P < 0.05) between base-
line and HEC conditions, hindlimb glucose uptake 
likewise increased (P < 0.05) to similar rates in all 
fetuses. Hindlimb glucose oxidation was increased 
(P  <  0.05) by HEC in all fetuses, but the change 
was substantially less (P < 0.05) in MI-IUGR fetus 
compared to controls. There were no differences be-
tween treatments or periods for hindlimb lactate se-
cretion (Table 1). In response to HEC, arterial pH 
was increased (P < 0.05) and arterial CO2 tended to 
be increased (P < 0.10) in all fetuses. Arterial HCO3 
content was reduced (P < 0.05) in MI-IUGR fetuses 
compared to controls regardless of condition.
Ex Vivo Skeletal Muscle Metabolism
Glucose uptake in primary soleus muscle was 
similar in all fetuses at each condition (Figure 3). 
Glucose oxidation rates were similar in all fetuses 
under basal conditions, but insulin- and TNFα-
stimulated glucose oxidation rates were decreased 
(P < 0.05) in soleus muscle from MI-IUGR fetuses.
DISCUSSION
In the present study, chronic maternal inflamma-
tion yielded IUGR and muscle-centric adaptations 
that shift glucose metabolism. Our MI-IUGR fetuses 
oxidized substantially smaller amounts of glucose 
within hindlimb tissues with no change in hindlimb 
glucose uptake. This was due to poor responsiveness 
to metabolic stimulators, as basal glucose oxidation 
in primary muscle strips from MI-IUGR fetuses was 
normal but insulin- and TNFα-stimulated glucose 
oxidation were decreased. Additionally, MI-IUGR 
fetuses exhibited poor β cell function that was related to 
reduced islet responsiveness to glucose. These findings 
Table 1. Fetal blood analysis during HEC study
Control MI-IUGR P value
Basal HEC Basal HEC Treatment Period T * P
n 4 4 4 4
Plasma insulin, ng/mL 0.37 ± 1.9 0.64 ± 1.2 15.63 ± 1.9 14.39 ± 1.2 NS <0.001 NS
Arterial pH 7.38 ± 0.02 7.35 ± 0.01 7.33 ± 0.02 7.334 ± 0.01 NS 0.05 NS
Arterial pCO2, mmHg 52.9 ± 1.7 52 ± 0.5 57 ± 1.7 53.7 ± 0.5 NS 0.06 NS
Arterial HCO3, mM 30.3 ± 0.5 28.6 ± 0.2 29.4 ± 0.5 27.9 ± 0.3 <0.001 NS NS
Values are expressed as means ± SE.
Figure 3. Ex vivo skeletal muscle glucose uptake (A) and oxidation 
(B) under basal, insulin, and TNFα-stimulated conditions measured 
in control (n = 8) and IUGR (n = 6) fetuses. a,b,cMeans with differing 
superscripts differ (P < 0.05).
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indicate that chronic maternal inflammation restricts 
fetal growth and produces a metabolic phenotype that 
mirrors other IUGR models. Thus, inflammation is 
likely a key part of the adaptive fetal programming 
that increases the risk for metabolic dysfunction in 
IUGR-born offspring. We attribute reduced muscle 
glucose oxidation to a shift toward anaerobic gly-
colysis (Brown et  al., 2015), which produces lactate 
that can be utilized by crucial organs such as the brain 
and heart (Yates et al., 2012a). Although circulating 
lactate was not different in the present study, it is likely 
that lactate was being cleared by the MI-IUGR liver 
for gluconeogenesis (Limesand et al., 2007). Impaired 
β cell function at hyperglycemia but not resting condi-
tions indicates that the disruption is in stimulus-secre-
tion coupling (i.e., the ability of β cells to respond to 
rising glucose). Previous studies show that other stress 
factors act similarly (Yates et al., 2012b; Chen et al., 
2014). Leukocytes are potent cytokine producers, and 
reduced circulating WBC counts in MI-IUGR fetuses 
despite greater counts in ewes indicates a compensa-
tory action by the fetus to moderate the heightened 
inflammatory environment. Although circulating 
cytokine concentrations were not determined in these 
fetuses, we previously observed increased plasma 
TNFα in rat fetuses well after maternal inflammation 
has subsided (Cadaret et al., 2017a).
IMPLICATIONS
Chronic maternofetal inflammation resulted 
in IUGR fetuses with altered muscle metabolic 
capacity and reduced β cell function. This pheno-
type is characteristic of low birth weight humans 
and livestock, and thus our findings indicate that 
fetal adaptations to chronic inflammation are a 
major factor in the development of low birthweight 
pathologies. Furthermore, muscle-centric adaptive 
fetal programming of inflammatory regulation may 
be a target for interventions to improve outcomes 
in low birthweight offspring.
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